25263-44-9

Basic information

• Product Name: M-HYDROXY BENZYL CYANIDE
• Synonyms: 3-HYDROXYPHENYLACETONITRILE;M-HYDROXYPHENYLACETONITRILE;M-HYDROXY BENZYL CYANIDE;M-HYDROXY BENZYL CYANIDE(3-HYDROXYPHENYL)-ACETONITRILE;2-(3-hydroxyphenyl)acetonitrile;3-Hydroxy-Benzeneacetonitrile
• CAS NO: 25263-44-9
• Molecular Formula: C₈H₇NO
• Molecular Weight: 133.15
• Product Categories: Aromatic Nitriles
• Mol File: 25263-44-9.mol
• Article Data: 9

Chemical Properties

• Melting Point: 53 °C
• Boiling Point: 305.5°C at 760 mmHg
• Flash Point: 138.6 °C
• Appearance: /
• Density: 1.167 g/cm³
• Vapor Pressure: 0.000452mmHg at 25°C
• Refractive Index: 1.573
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 9.51±0.10(Predicted)
• CAS DataBase Reference: M-HYDROXY BENZYL CYANIDE(CAS DataBase Reference)
• NIST Chemistry Reference: M-HYDROXY BENZYL CYANIDE(25263-44-9)
• EPA Substance Registry System: M-HYDROXY BENZYL CYANIDE(25263-44-9)

Safety Data

• Hazardous Substances Data: 25263-44-9(Hazardous Substances Data)

Usage

Uses

2-(3-Hydroxyphenyl)acetonitrile is used in preparation of Pyrrolidine Sulfonamide compounds as TRPV4 antagonists.

InChI:InChI=1/C8H7NO/c9-5-4-7-2-1-3-8(10)6-7/h1-3,6,10H,4H2

Upstream product

• 4623-24-9 2-(3-aminophenyl)acetonitrile 
• 122-46-3 3-acetoxytoluene 
• 49617-80-3 m-(bromomethyl)phenyl acetate 
• 19924-43-7 3-methoxyphenylacetonitrile 
• 140-29-4 phenylacetonitrile 
• 621-50-1 (3-nitrophenyl)acetonitrile 

Downstream Products

• 123724-18-5 2-<<3-(cyanomethyl)phenoxy>methyl>quinoline 
• 82134-66-5 methyl 3-<<3-(cyanomethyl)phenyl>oxy>propanoate 
• 20967-96-8 2-(3-benzyloxyphenyl)acetonitrile 
• 259538-74-4 tert-Butyl (2 R)-2-{[3-(cyanomethyl)phenoxy]methyl}-1-pyrrolidinecarboxylate 
• 120028-55-9 3-(2-quinazolinylmethoxy)benzenacetonitrile 
• 107223-46-1 [3-(4-Acetyl-3-hydroxy-2-propyl-benzyloxy)-phenyl]-acetonitrile 
• 621-37-4 m-hydroxyphenylacetic acid 
• 1193434-40-0 5-(3-(2,6-dimethylbenzyloxy)benzyl)-1H-tetrazole 
• 1307837-71-3 C₁₁H₁₂O₃ 

Relevant articles and documents

TETRAZOLE COMPOUNDS FOR REDUCING URIC ACID

Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including g

FLUORINATED ARYLALKYLAMINOCARBOXAMIDE DERIVATIVES

Fluorinated arylalkylaminocarboxamide derivatives of formula (I) are described wherein W, J, n, R1, R2, R2', R3, R4, R5 and R6 have the meanings as defined in the specification a

Novel azo dye compound

A compound represented by formula (I): Formula (I) wherein Z1 and Z2 each are atoms necessary for forming an aromatic ring; V1 and V2 each are a substituent W1 or W2; when at least one V1 is W1, at least one V2 is W2, or when at least one V1 is W2, at least one V2 is W1; r is 1 to 4; s is 1 to 4; M1 is a counter ion; m1 is the number necessary for neutralizing charge; W1 is a hydroxyl, primary- or secondary- or tertiary-amino, acylamino, or sulfonamido group; W2 is a nitro, cyano, alkoxycarbonyl, aryloxycarbonyl, alkyl- or aryl-sulfonyl, carbamoyl, sulfamoyl, alkenyl, alkynyl, aryl, heterocyclic, sulfo, carboxyl, heterocyclic oxy, ammonio, alkyl- or aryl-sulfinyl, alkyl- or aryl-sulfonyl, acyl, or aryl- or heterocyclic-azo group; and the aromatic ring may have a substituent other than V1 and V2.